| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | apixaban | FAERS: 5 | US FAERS | |
| 2 | Arthrotec | FAERS: 4 | US FAERS | |
| 3 | Dabigatran | FAERS: 2 | US FAERS | |
| 4 | Alendronate | FAERS: 1 | US FAERS | |
| 5 | Clopidogrel | FAERS: 1 | US FAERS | |
| 6 | Diclofenac | FAERS: 1 | US FAERS | |
| 7 | Dipyridamole | FAERS: 1 | US FAERS | |
| 8 | Fentanyl | FAERS: 1 | US FAERS | |
| 9 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 10 | Omeprazole | FAERS: 1 | US FAERS | |
| 11 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 12 | Varenicline | FAERS: 1 | US FAERS | |
| 13 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 14 | Bromazepam | OFFSIDES | ||
| 15 | Busulfan | OFFSIDES | ||
| 16 | ethyl loflazepate | OFFSIDES | ||
| 17 | etizolam | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.